Clinical Trials Directory

Trials / Completed

CompletedNCT04383106

Bowel Colonization With Multi-drug Resistant Bacterial Species in Hospitalized Patients With acute-on Chronic Liver Failure (ACLF), and Its Relationship With Extra-intestinal Infectious Events and Short-term Outcomes.

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Institute of Liver and Biliary Sciences, India · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Bowel colonization with anti-microbial resistant bacteria increases the risk of clinical infections. Infections caused by anti-microbial resistant bacteria have been associated with increased mortality, prolonged hospital stay, and increased costs. In addition, with the emergence of carbapenemase resistant bacterial species, there may not be any effective therapy for patients infected with such resistant species. Bowel colonization with anti-microbial resistant bacteria is an established risk factor for infections due to resistant bacteria, especially in transplanted patients and in intensive care unit. In this study we will study whether bowel colonisation in Acute on Chronic Liver Failure patient increases the risk of infection development in extra intestinal sites.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2020-06-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2020-05-12
Last updated
2024-03-05

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04383106. Inclusion in this directory is not an endorsement.